Menveo
- Licence status
- Active substances
- N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN
- Dosage Form
- Solution for injection
- Licence number
- EU/1/10/614/002-004
- Licence holder
- Glaxosmithkline Vaccines S.r.l.
Product documents
Licence information
- ATC code
- J07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to medical prescription. • Official batch release In accordance with Article 114 of Directive 2001/83/EC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 25/11/2024